Description

Femoston (Estradiol/Dydrogesterone) Coated Tablets 1 mg/10 mg – Pack of 56 Tablets

Composition:

Each tablet contains 1 mg of estradiol and 10 mg of dydrogesterone.

Mechanism of Action:

Estradiol, a type of estrogen, alleviates menopausal symptoms like hot flashes and vaginal dryness. Dydrogesterone, a progestogen, safeguards the uterine lining from estrogen’s impacts.

Pharmacological Properties:

The combination of estradiol and dydrogesterone in Femoston offers effective relief from menopausal symptoms while reducing the risk of endometrial hyperplasia.

Indications for Use:

Femoston tablets are prescribed for hormone replacement therapy in postmenopausal women with an intact uterus.

Contraindications:

Avoid using Femoston if there is a history of breast cancer, liver disease, or unexplained vaginal bleeding.

Side Effects:

Common side effects may include nausea, breast tenderness, headache, and breakthrough bleeding. Contact your healthcare provider if you experience any unusual symptoms.

Usage Instructions:

Take one tablet orally daily, preferably at the same time each day. Swallow the tablet whole with water; do not crush or chew it.

Benefits Compared to Analogues:

Femoston offers a balanced combination of estradiol and dydrogesterone, providing effective relief from menopausal symptoms with a reduced risk of endometrial hyperplasia compared to other hormone replacement therapies.

Suitable Patient Groups:

Femoston is suitable for postmenopausal women with an intact uterus. Dosage adjustments may be necessary for elderly patients; consult a healthcare provider for personalized recommendations.

Storage Conditions and Shelf Life:

Store Femoston in a cool, dry place away from direct sunlight. Check the expiration date on the packaging and do not use the tablets after the specified shelf life.

Packaging Description:

Femoston is available in a pack containing 56 coated tablets. The packaging is designed to maintain the quality and integrity of the tablets.

Clinical Evidence and Proven Effectiveness:

Estradiol and dydrogesterone in Femoston have been clinically proven to effectively manage menopausal symptoms while minimizing the risk of endometrial hyperplasia. Consult your healthcare provider for more information specific to your condition.